Delivery Order SPE2DB24D2205-SPE2DB25FEEGY
Award Date 6/30/25
Potential Completion Date 7/1/25
Potential Value $8.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,792,418 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML medical product. The $20,129.39 firm-fixed-price contract has a completion date of June 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,154.47 firm-fixed-price delivery order is for the supply of 4,566,178,920 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,873.47 firm-fixed-price delivery order contract is for MONOVISC 88 MG/4 ML syringes. The contract has an ultimate completion date of December 26, 2023 and is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,290,496 units of MONOVISC 88 MG/4 ML SYRINGE 4ML, with a total ceiling value of $2,671.26. The delivery order has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation mentioned. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,338.72 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $4,647.12 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,275.70 firm fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has a period of performance through May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $4,647.12 for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract, which has a completion date of June 28, 2024, was awarded by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company,...
- This is a delivery order under contract SPE2DX15D1053 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,557,830,548 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The total ceiling value of this delivery order is $11,042.26, with a firm fixed price pricing type. The order has a completion date of July 19, 2022. Amerisourcebergen, a major...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for MONOVISC 88 MG/4 ML SYRINGE 4ML. The firm-fixed-price contract has a ceiling value of $9,125.06 and a period of performance through May 6, 2025. The award is not set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEGYDelivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $8,462.99, is a firm fixed-price delivery order for 4,568,677,123 units of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of July 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is not designated as a set-aside contract.
Generated 10/5/25, 1:00 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 6/30/25 |